Merger and acquisition activity is at a seven-year low in 2024 as buyers digest prior deals and US election jitters delayed further spending. Expect a pick-up in 2025.

中文翻译：

---

生物制药交易规模变小、时间变早


2024 年，并购活动处于七年来的最低点，因为买家消化了之前的交易，而美国大选的紧张情绪推迟了进一步的支出。预计 2025 年会有所回升。